Does DAUNORUBICIN Cause Second primary malignancy? 106 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Second primary malignancy have been filed in association with DAUNORUBICIN (Daunorubicin Hydrochloride). This represents 1.1% of all adverse event reports for DAUNORUBICIN.
106
Reports of Second primary malignancy with DAUNORUBICIN
1.1%
of all DAUNORUBICIN reports
73
Deaths
26
Hospitalizations
How Dangerous Is Second primary malignancy From DAUNORUBICIN?
Of the 106 reports, 73 (68.9%) resulted in death, 26 (24.5%) required hospitalization, and 17 (16.0%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAUNORUBICIN. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does DAUNORUBICIN Cause?
Febrile neutropenia (1,311)
Pyrexia (645)
Neutropenia (631)
Sepsis (515)
Off label use (462)
Pneumonia (402)
Bacterial infection (400)
Drug ineffective (375)
Septic shock (363)
Thrombocytopenia (347)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which DAUNORUBICIN Alternatives Have Lower Second primary malignancy Risk?
DAUNORUBICIN vs DAXIBOTULINUMTOXIN A-LANM
DAUNORUBICIN vs DAYTRANA
DAUNORUBICIN vs DECITABINE
DAUNORUBICIN vs DEFERASIROX
DAUNORUBICIN vs DEFERIPRONE